RAPAFUSYN PHARMACEUTICALS
Rapafusyn Pharmaceuticals licenses technology related to a novel class of natural product-like macrocycle. The company develops novel pharmaceuticals to treat patients having diseases and fulfill other unmet medical needs.
RAPAFUSYN PHARMACEUTICALS
Industry:
Biotechnology
Address:
Baltimore, Maryland, United States
Country:
United States
Website Url:
http://www.rapafusyn.com
Status:
Active
Contact:
(410) 995-8234
Email Addresses:
[email protected]
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS
Official Site Inspections
http://www.rapafusyn.com
- Host name: 0.120.215.35.bc.googleusercontent.com
- IP address: 35.215.120.0
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Rapafusyn Pharmaceuticals"
RAPAFUSYN
At Rapafusyn, we are developing non-degrading molecular glues to tackle difficult drug targets to improve patient outcomes. Rapafusyn has designed and generated large DNA encoded …See details»
About Us - RAPAFUSYN
At Rapafusyn, we are developing non-degrading molecular glues to tackle difficult drug targets to improve patient outcomes. Rapafusyn has designed and generated large DNA encoded …See details»
Rapafusyn Pharmaceuticals - Crunchbase Company …
Rapafusyn Pharmaceuticals licenses technology related to a novel class of natural product-like macrocycle. The company develops novel pharmaceuticals to treat patients having diseases and fulfill other unmet medical needs.See details»
Team — RAPAFUSYN
[email protected] 410-995-8234. Privacy Policy. All Rights Reserved Copyright 2022 Rapafusyn PharmaceuticalsSee details»
Rapafusyn Pharmaceuticals - LinkedIn
Rapafusyn Pharmaceuticals | 640 followers on LinkedIn. Rapafusyn Pharmaceuticals is an emerging pharmaceutical development company located in Baltimore Maryland.See details»
Drug Librarian Discovers New Compound That May …
Feb 20, 2019 · It also has licensed the drug to Baltimore-based biotechnology company Rapafusyn Pharmaceuticals, which was co-founded by the study’s leader, Jun O. Liu, Ph.D., a professor of pharmacology and oncology at the …See details»
Rapafusyn Pharmaceuticals - Overview, News & Similar
View Rapafusyn Pharmaceuticals (www.rapafusyn.com) location in Maryland, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Rapafusyn Pharmaceuticals Company Profile - Office Locations
Rapafusyn Pharmaceuticals is a pharmaceutical development company. It licenses technology related to natural product-like macrocycles and develops pharmaceuticals to treat patients …See details»
Rapafusyn Pharmaceuticals Secures $28 Million Series A to …
Jun 20, 2024 · Rapafusyn Pharmaceuticals, a leader in the discovery and development of therapeutic drugs based on non-degrading molecular glues, today announced the initial …See details»
Rapafusyn Pharmaceuticals, Inc. - VentureRadar
At the core of Rapafusyn’s platform are its proprietary diverse libraries of FKBP-binding bi-functional macrocycles (rapafucins). These rapafucin-FKBP complexes then present the …See details»
Rapafusyn Pharmaceuticals - Contacts, Employees, Board …
Rapafusyn Pharmaceuticals licenses technology related to a novel class of natural product-like macrocycle.See details»
Rapafusyn Pharmaceuticals - Updates, News, Events, Signals
Jul 1, 2024 · Rapafusyn Pharmaceuticals, a Baltimore-based company specializing in therapeutic drug development, has raised $28 million in Series A funding. The investment will support the …See details»
Rapafusyn Pharmaceuticals Raises $28M in Series A Funding
Jun 24, 2024 · Rapafusyn Pharmaceuticals, a Baltimore, MD-based company which specializes in the discovery and development of therapeutic drugs based on non-degrading molecular glues, …See details»
Rapafusyn_Raised_28mil – Boston Capital Investment Club
Jun 20, 2024 · Congratulation on Rapafusyn Pharmaceuticals for raising $28 milllion successfully in its series A funding round. Rapafusyn Pharmaceuticals was awarded with Third Prize award …See details»
Rapafusyn Pharmaceuticals Secures $28 Million Series A to …
Jun 20, 2024 · Rapafusyn Pharmaceuticals, a leader in the discovery and development of therapeutic drugs based on non-degrading molecular glues, today announced the initial …See details»
Rapafusyn Developing Compound That May Thwart Common …
In a strategic search, Johns Hopkins scientists created and screened a library of 45,000 new compounds containing chemical elements of widely used immune system suppressants, and …See details»
Rapafusyn Pharma Raises $28 Million for Molecular Glues from …
Jun 21, 2024 · Baltimore’s Rapafusyn Pharma, a novel drug company based on non-degrading molecular glues, extended its Series A financing, bringing the total to $28 Million. The …See details»
PUBLICATIONS — RAPAFUSYN
[email protected] 410-995-8234. Privacy Policy. All Rights Reserved Copyright 2022 Rapafusyn PharmaceuticalsSee details»
Rick Ewing - Rapafusyn Pharmaceuticals - LinkedIn
Senior Level Medicinal Chemist experienced in leading teams to deliver development… · Experience: Rapafusyn Pharmaceuticals · Location: Morrisville · 500+ connections on LinkedIn.See details»
药品“库管员”发现新化合物, 有望预防常见手术并发症 | Johns …
Feb 20, 2019 · 该约翰·霍普金斯大学团队将此新发现的化合物称为 rapadocin，并为它和相关 45000 种化学同类物申请了专利。同时，该团队还将此药授权给总部位于巴尔的摩的生物科技 …See details»